Journal of Clinical and Diagnostic Research (Oct 2018)
Effect of Wharton’s Jelly Derived Mesenchymal Stem Cells on the Expression of NLRP3 Receptor and Neuroinflammation in Experimental Spinal Cord Injury
Abstract
Introduction: The NOD-Like Receptor (NLR) family, pyrin domaincontaining protein 3 (NLRP3) inflammasome plays a major role in inflammation process. Structurally, the inflammasome consists of a receptor (NLRP3), an adaptor protein, and precursor of the enzyme caspase-1. Inflammasome activation in central nervous system injuries can activate caspase-1. This enzyme mediates the maturation and secretion of interleukin-1β (IL-1β) and IL-18, initiating inflammatory responses. Mesenchymal stem cells have shown immune modulation features and have been extensively used for treating inflammatory diseases. Aim: To investigate the effect of intracisternal transplantation of Wharton’s Jelly-Derived Mesenchymal stem Cells (WJMSCs) on the NLRP3 inflammasome in Spinal Cord Injury (SCI) rat model. Materials and Methods: Male wistar rats were divided into four groups (n=7) as following: laminectomy group, spinal cord injury group, vehicle group (the rats received phosphate-buffered saline), and WJMSCs treated group. Gene expression and protein production of NLRP3 receptor was evaluated by real time-PCR and western blotting. Serum concentration of IL-1β and IL-18 was measured by ELISA. Data were analysed using one-way ANOVA test followed by Tukey’s test. Results: The results showed that both gene and protein expressions of NLRP3 receptor were significantly increased in the SCI rats in comparison to the uninjured rats (p<0.05). In addition, the serum levels of IL-1β and IL-18 had upward trends in the SCI group compared to the laminectomy (p<0.05). On the other hand, WJMSCs significantly reversed the rises in both NLRP3 expression and interleukins amounts in comparison to the SCI group (p<0.05). Conclusion: It can be concluded that MSCs may modulate the inflammation process via inflammasome suppression.
Keywords